Oleanolic Acid, a Pentacyclic Triterpene Attenuates the Mustard Oil-Induced Colonic Nociception in Mice

• Published in: Biological & Pharmaceutical Bulletin 2006, Vol.29(1), pp.82-85
• Main Authors: Maia, Juliana Lemos, Lima-Júnior, Roberto César Pereira, David, Juceni Pereira, David, Jorge Mauricio, Santos, Flávia Almeida, Rao, Vietla Satyanarayana
• Format: Article
• Language: English
• Subjects: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists - pharmacology; Animals; antinociceptive activity; Behavior, Animal - drug effects; Colonic Diseases - chemically induced; Colonic Diseases - prevention & control; Dose-Response Relationship, Drug; Male; Mice; Motor Activity - drug effects; mustard oil; Mustard Plant - chemistry; Mustard Plant - toxicity; oleanolic acid; Oleanolic Acid - pharmacology; Pain - chemically induced; Pain - prevention & control; pentacyclic triterpene; Plant Oils - toxicity; Ruthenium Red - pharmacology; TRPV Cation Channels - metabolism; visceral nociception; Yohimbine - pharmacology
• ISSN: 0918-6158; 1347-5215
• DOI: 10.1248/bpb.29.82

Many natural terpenoid compounds from plants exhibit antinociceptive property but very few studies have addressed their efficacy in visceral models of nociception. The present study evaluated the antinociceptive potential of oleanolic acid, a pentacyclic triterpene in the mouse model of colonic nociception induced by mustard oil. We further examined the possible participation of opioid, α2-adrenergic, and transient receptor potential vanilloid 1 (TRPV1)-receptors in its mechanism. Mice were pretreated orally with oleanolic acid (3, 10, 30 mg/kg) or vehicle, and the pain-related behavioral responses to intracolonic injection of mustard oil was analysed. Oleanolic acid significantly suppressed the mustard oil-induced nociceptive behaviors at test doses of 10 and 30 mg/kg, in a dose-related manner. The antinociceptive effect of oleanolic acid (30 mg/kg) was significantly blocked by pretreatment with the opioid antagonist, naloxone (2 mg/kg, i.p.), while the α2-adrenoceptor antagonist, yohimbine (2 mg/kg, s.c.), had no effect. Pretreatment with ruthenium red (3 mg/kg, s.c.), a non-competitive TRPV1 antagonist alone caused significant inhibition of mustard oil-induced nociception but its co-administration with oleanolic acid produced neither antagonism nor potentiation of oleanolic acid antinociception. In the open-field test that detects sedative or motor abnormality, mice received 30 mg/kg oleanolic acid did not show any per se influence, but significantly inhibited the mustard oil-induced decrease in ambulation frequency. These data demonstrate the visceral antinociceptive potential of oleanolic acid that involves an opioid mechanism and possibly a modulatory influence on vanilloid-receptors, which needs further study.